Literature DB >> 6337573

Nontuberculous mycobacterial disease. Experience in a southern California hospital.

G J Gorse, R D Fairshter, G Friedly, L Dela Maza, G R Greene, T C Cesario.   

Abstract

The experience with nontuberculous mycobacterial disease at an "acute-care" hospital in southern California between 1971 and 1981 is reported. Forty-five patients with nontuberculous mycobacterial or Mycobacterium bovis-caused disease were identified by retrospective review. Of these, 31 patients (69%) had pulmonary infection alone, nine (20%) had cervical lymphadenitis, two (4%) had disseminated disease, two (4%) had cutaneous infection, and one had soft tissue infection. Nonmycobacterial pulmonary disease was noted in 15 (33%) of the patients and underlying malignant neoplasms were noted in eight (18%). Symptoms most frequently reported at initial examinations of patients with pulmonary disease were cough, weight loss, sputum production, and fatigue. Response to therapy was more successful in patients with Mycobacterium kansasii-caused disease than in those with Mycobacterium avium-intracellulare-caused pulmonary disease. We conclude that nontuberculous mycobacterial disease is not rare in the general hospital setting in southern California.

Entities:  

Mesh:

Year:  1983        PMID: 6337573     DOI: 10.1001/archinte.143.2.225

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

Review 1.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.

Authors:  Theodore K Marras; Mauli Mehta; Pamela Chedore; Kevin May; Mohammed Al Houqani; Frances Jamieson
Journal:  Lung       Date:  2010-04-11       Impact factor: 2.584

3.  Mycobacterium kansasii pulmonary infection: CT findings in 29 cases.

Authors:  Masashi Takahashi; Hiroaki Tsukamoto; Tetsuji Kawamura; Yoshirou Mochizuki; Masatsugu Ouchi; Shuhei Inoue; Norihisa Nitta; Kiyoshi Murata
Journal:  Jpn J Radiol       Date:  2012-02-24       Impact factor: 2.374

4.  Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies.

Authors:  F Alcaide; I Richter; C Bernasconi; B Springer; C Hagenau; R Schulze-Röbbecke; E Tortoli; R Martín; E C Böttger; A Telenti
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Superoxide dismutase activity of Mycobacterium avium, M. intracellulare, and M. scrofulaceum.

Authors:  B K Mayer; J O Falkinham
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

6.  Nontuberculous mycobacterial infection in HIV-negative patients receiving immunosuppressive therapy.

Authors:  K Skogberg; P Ruutu; P Tukiainen; V V Valtonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 7.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

8.  Risk factors for developing Mycobacterium kansasii lung disease: A case-control study in Korea.

Authors:  Jin Hyoung Kim; Kwang Won Seo; Yongjoon Shin; Ji Seon Oh; Jae-Bum Jun; Joseph Jeong; Chang Sun Sim; Seunghee Baek; Taehoon Lee; Jong Joon Ahn
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.